Literature DB >> 18978274

Perthes' disease and the search for genetic associations: collagen mutations, Gaucher's disease and thrombophilia.

G Kenet1, E Ezra, S Wientroub, D M Steinberg, N Rosenberg, D Waldman, S Hayek.   

Abstract

The role of heritable thrombophilic risk factors in the pathogenesis of the Perthes' disease is controversial. The clinical and radiological findings of Perthes' disease may be indistinguishable from those of Gaucher's disease, and the most common Jewish N370S Gaucher mutation is threefold greater in patients with Perthes' disease. Familial osteonecrosis of the femoral head is associated with variant mutations of collagen type II (COL2A1 mutations). We therefore studied the potential role of genetic thrombophilia and the Gaucher and COL2A1 mutations in children with Perthes' disease. Genomic DNA of 119 children with radiologically-confirmed Perthes' disease diagnosed between 1986 and 2005 was analysed for the thrombophilic polymorphisms Factor V Leiden, 677T-MTHFR and FIIG20210A. The results were compared with those of a group of 276 children without Perthes' disease. DNA was also analysed for the Gaucher mutations N370S, G insertion (84GG), L444P, Intron 2 (IVS2+1G>A) and R496H. Enzymic assays confirmed the Gaucher disease status. Collagen (COL2A1) mutations of the 12q13 gene were also analysed. The prevalence of thrombophilic markers was similar among the 119 patients with Perthes' disease and the 276 control subjects. The prevalence of the Gaucher mutation was consistent with Israeli population carriership data and did not confirm an earlier-claimed association with Perthes' disease. All 199 patients were negative for the studied COL2A1 mutations. We found no genetic association between Perthes' disease and either Gaucher's disease or COL2A1 mutations or increased genetic thrombophilia among our patients compared with the control group. A systematic review of case-control studies suggested that there was a positive association between Perthes' disease and Factor V Leiden. The impact of this association upon the disease, although not consistent across the studies, remains unclear.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18978274     DOI: 10.1302/0301-620X.90B11.20318

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  4 in total

Review 1.  Legg-Calvé-Perthes syndrome (LCPS): an up-to-date critical review Charles W. Goff, MD CORR 1962;22:93-107.

Authors:  Richard A Brand
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

2.  Two novel COL2A1 mutations associated with a Legg-Calvé-Perthes disease-like presentation.

Authors:  Peter Kannu; Melita Irving; Salim Aftimos; Ravi Savarirayan
Journal:  Clin Orthop Relat Res       Date:  2011-03-26       Impact factor: 4.176

Review 3.  The epidemiology and demographics of legg-calvé-perthes' disease.

Authors:  Randall T Loder; Elaine N Skopelja
Journal:  ISRN Orthop       Date:  2011-09-05

4.  Does early and aggressive management of significant extrusion of the femoral head affect the outcome of Perthes' disease with the age of onset younger than 7 years?

Authors:  K A Singh; N Harne; H Shah
Journal:  Musculoskelet Surg       Date:  2021-04-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.